OPTIEK DEPRIL financials
A multi-period view of the public annual-account figures reported for OPTIEK DEPRIL, with comparable measures and links to available source documents.
Company overviewRegistry number
0867656783
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for OPTIEK DEPRIL
2025 versus 2024
- Operating line
- €164,484
- EBITDA
- €162,568
- Total assets
- €534,902
- Equity
- €483,346
-16.3%
-16.4%
+17.7%
+24.4%
EBITDA margin +98.8% · Equity ratio +90.4%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €164,484 | €162,568 | €534,902 | €483,346 | - |
| 202431 Dec 2024 | €196,442 | €194,518 | €454,506 | €388,645 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.